Srs Capital Advisors, Inc. Pfizer Inc Transaction History

Srs Capital Advisors, Inc.

$901 Million
Q1 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 8,452 shares of PFE stock, worth $234,289. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,452

Previous 8,324 1.54%

Holding current value

$234,289

Previous $239,000 2.09%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $3,313 - $3,805	128 Added 1.54%	8,452 $234,000
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $41,259 - $53,591	-1,579 Reduced 15.94%	8,324 $239,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $28,816 - $33,683	-898 Reduced 8.31%	9,903 $328,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $144,841 - $167,577	-4,010 Reduced 27.07%	10,801 $396,000
Q1 2023 May 16, 2023	SELL	$39.39 - $51.28 $6,617 - $8,615	-168 Reduced 1.12%	14,811 $604,000

Q4 2022 Feb 24, 2023	BUY	$41.75 - $54.5 $5,051 - $6,594	121 Added 0.81%	14,979 $767,000
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $54,262 - $66,240	1,240 Added 9.11%	14,858 $650,000
Q2 2022 Aug 22, 2022	BUY	$46.53 - $55.17 $10,143 - $12,027	218 Added 1.63%	13,618 $714,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $9,790 - $12,131	214 Added 1.62%	13,400 $694,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $241,102 - $357,393	5,835 Added 79.38%	13,186 $779,000
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $19,821 - $25,462	505 Added 7.38%	7,351 $316,000
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $127,839 - $144,820	-3,560 Reduced 34.21%	6,846 $268,000
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $1,907 - $2,425	57 Added 0.55%	10,406 $383,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $97,821 - $114,767	3,081 Added 42.39%	10,349 $380,000
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $97,046 - $117,731	-3,222 Reduced 30.71%	7,268 $238,000
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $276,516 - $395,082	-10,230 Reduced 49.37%	10,490 $342,000
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $1,218 - $1,382	-37 Reduced 0.18%	20,720 $812,000
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $1,494 - $1,937	46 Added 0.22%	20,757 $746,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $31,322 - $35,167	-847 Reduced 3.93%	20,711 $897,000
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $194,119 - $221,317	5,046 Added 30.56%	21,558 $941,000
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $55,979 - $67,899	-1,624 Reduced 8.95%	16,512 $728,000
Q2 2018 Aug 21, 2018	BUY	$32.98 - $35.16 $58,242 - $62,092	1,766 Added 10.79%	18,136 $657,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $8,679 - $10,069	-272 Reduced 1.63%	16,370 $580,000
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $4,922 - $5,222	148 Added 0.9%	16,642 $602,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $511,314 - $563,270	16,494	16,494 $588,000

Others Institutions Holding PFE

# of Institutions

3,164

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Pfizer Inc Transaction History